Spire Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.9K Sell
2,012
-6,301
-76% -$342K ﹤0.01% 1018
2026
Q1
$522K Sell
8,313
-11,467
-58% -$917K 0.02% 531
2025
Q4
$1.89M Sell
19,780
-3,289
-14% -$322K 0.06% 264
2025
Q3
$2.25M Buy
23,069
+3,941
+21% +$408K 0.08% 209
2025
Q2
$2.05M Buy
19,128
+8,498
+80% +$860K 0.07% 220
2025
Q1
$1.07M Buy
10,630
+1,456
+16% +$147K 0.03% 387
2024
Q4
$819K Buy
9,174
+1,865
+26% +$164K 0.03% 434
2024
Q3
$612K Buy
7,309
+4,630
+173% +$365K 0.02% 476
2024
Q2
$206K Sell
2,679
-7
-0.3% -$512 0.01% 710
2024
Q1
$184K Buy
2,686
+530
+25% +$34.1K ﹤0.01% 789
2023
Q4
$131K Sell
2,156
-1,154
-35% -$61.6K ﹤0.01% 917
2023
Q3
$175K Buy
3,310
+53
+2% +$2.78K 0.01% 750
2023
Q2
$176K Buy
3,257
+897
+38% +$46.9K 0.01% 765
2023
Q1
$118K Buy
2,360
+995
+73% +$46.9K ﹤0.01% 910
2022
Q4
$63K Sell
1,365
-458
-25% -$19.8K ﹤0.01% 906
2022
Q3
$71K Sell
1,823
-931
-34% -$37.3K ﹤0.01% 823
2022
Q2
$103K Sell
2,754
-3
-0.1% -$122 ﹤0.01% 1023
2022
Q1
$122K Sell
2,757
-1,364
-33% -$59.1K ﹤0.01% 1101
2021
Q4
$175K Buy
4,121
+1,550
+60% +$65.1K ﹤0.01% 1147
2021
Q3
$112K Sell
2,571
-13,060
-84% -$578K ﹤0.01% 1151
2021
Q2
$668K Sell
15,631
-2,829
-15% -$119K 0.02% 531
2021
Q1
$713K Buy
+18,460
New +$699K 0.02% 554

Other funds holding BSX

Spire Wealth Management's BSX Position: Q2 2026 in Review

Spire Wealth Management reduced its Boston Scientific (BSX) stake by 76% in Q2 2026, selling an estimated $342K and leaving 2,012 shares worth $85.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Spire Wealth Management first reported a position in BSX in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.25M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Spire Wealth Management held 2,012 shares of Boston Scientific worth $85.9K as of Q2 2026.
  • Spire Wealth Management sold 6,301 Boston Scientific shares in Q2 2026, an estimated $342K.
  • Boston Scientific made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1018 holding.
  • Spire Wealth Management first reported a position in Boston Scientific in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Boston Scientific position peaked at $2.25M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.